Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
5.42 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -49.12 | -33.608 | -23.014 | -21.355 |
| Depreciation & Amortization
| 0.287 | 0.222 | 0.181 | 0.137 |
| Deferred Income Tax
| -8.071 | -3.635 | 0.288 | 0 |
| Stock Based Compensation
| 7.625 | 3.413 | 0.302 | 0.221 |
| Change In Working Capital
| -3.307 | -0.451 | 2.597 | -8.12 |
| Accounts Receivables
| -0.003 | 0.025 | 0.047 | -0.079 |
| Inventory
| 0.131 | -0.208 | 0.001 | -0.026 |
| Accounts Payables
| 0.145 | 0.183 | 1.078 | -2.607 |
| Other Working Capital
| -3.58 | -0.451 | 1.471 | -5.408 |
| Other Non Cash Items
| 6.459 | 4.77 | 0.217 | 2.934 |
| Operating Cash Flow
| -46.127 | -29.289 | -19.429 | -26.183 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.078 | -0.591 | -0.274 | -0.539 |
| Acquisitions Net
| -10.765 | -29.06 | -13.291 | -27.505 |
| Purchases Of Investments
| -142.032 | -63.531 | -0.213 | -15.624 |
| Sales Maturities Of Investments
| 152.797 | 92.591 | 13.504 | 43.129 |
| Other Investing Activites
| 10.765 | -63.531 | 13.291 | 27.505 |
| Investing Cash Flow
| 10.687 | -64.122 | 13.017 | 26.966 |
| Financing Activities: | ||||
| Debt Repayment
| -10.849 | -3.554 | -4 | -10 |
| Common Stock Issued
| 0.254 | 0.19 | 0 | 162.285 |
| Common Stock Repurchased
| 0 | -92.591 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 56.81 | 99.513 | 0.007 | -152.285 |
| Financing Cash Flow
| 46.215 | 103.257 | -3.993 | 10 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 11.425 | 0 | 0 |
| Net Change In Cash
| 10.775 | 18.03 | -10.405 | 10.783 |
| Cash At End Of Period
| 30.559 | 19.784 | 9.938 | 20.343 |